Banks - Regional
Compare Stocks
4 / 10Stock Comparison
FUNC vs MNSB vs CARE vs FXNC
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
FUNC vs MNSB vs CARE vs FXNC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $248M | $176M | $580M | $253M |
| Revenue (TTM) | $112M | $136M | $255M | $112M |
| Net Income (TTM) | $25M | $16M | $31M | $18M |
| Gross Margin | 68.8% | 54.4% | 61.7% | 74.0% |
| Operating Margin | 24.4% | 14.0% | 15.7% | 19.6% |
| Forward P/E | 8.7x | 10.4x | 4.8x | 11.7x |
| Total Debt | $188M | $70M | $179M | $43M |
| Cash & Equiv. | $78M | $25M | $105M | $161M |
FUNC vs MNSB vs CARE vs FXNC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| First United Corpor… (FUNC) | 100 | 277.5 | +177.5% |
| MainStreet Bancshar… (MNSB) | 100 | 177.2 | +77.2% |
| Carter Bankshares, … (CARE) | 100 | 371.0 | +271.0% |
| First National Corp… (FXNC) | 100 | 210.5 | +110.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FUNC vs MNSB vs CARE vs FXNC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FUNC is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 289.2% 10Y total return vs FXNC's 241.1%
- PEG 0.77 vs FXNC's 7.87
- Lower P/E (8.7x vs 11.7x), PEG 0.77 vs 7.87
MNSB has the current edge in this matchup, primarily because of its strength in quality and efficiency.
- Efficiency ratio 0.4% vs FXNC's 0.5% (lower = leaner)
- Efficiency ratio 0.4% vs FXNC's 0.5%
CARE is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.56, Low D/E 42.5%, current ratio 0.75x
- Beta 0.56 vs FUNC's 0.72, lower leverage
- +69.0% vs MNSB's +26.4%
FXNC is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 11 yrs, beta 0.70, yield 2.2%
- Rev growth 27.1%, EPS growth 96.0%
- Beta 0.70, yield 2.2%, current ratio 0.10x
- NIM 3.6% vs CARE's 2.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.1% NII/revenue growth vs MNSB's -1.4% | |
| Value | Lower P/E (8.7x vs 11.7x), PEG 0.77 vs 7.87 | |
| Quality / Margins | Efficiency ratio 0.4% vs FXNC's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.56 vs FUNC's 0.72, lower leverage | |
| Dividends | 2.2% yield, 11-year raise streak, vs FUNC's 2.2%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +69.0% vs MNSB's +26.4% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs FXNC's 0.5% |
FUNC vs MNSB vs CARE vs FXNC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FUNC vs MNSB vs CARE vs FXNC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FXNC leads in 3 of 6 categories
FUNC leads 1 • CARE leads 1 • MNSB leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
FXNC leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CARE is the larger business by revenue, generating $255M annually — 2.3x FUNC's $112M. FUNC is the more profitable business, keeping 18.4% of every revenue dollar as net income compared to MNSB's 11.5%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $112M | $136M | $255M | $112M |
| EBITDAEarnings before interest/tax | $36M | $23M | $46M | $25M |
| Net IncomeAfter-tax profit | $25M | $16M | $31M | $18M |
| Free Cash FlowCash after capex | $16M | $13M | $30M | $21M |
| Gross MarginGross profit ÷ Revenue | +68.8% | +54.4% | +61.7% | +74.0% |
| Operating MarginEBIT ÷ Revenue | +24.4% | +14.0% | +15.7% | +19.6% |
| Net MarginNet income ÷ Revenue | +18.4% | +11.5% | +12.3% | +15.8% |
| FCF MarginFCF ÷ Revenue | +18.2% | +7.8% | +12.5% | +18.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +20.2% | +120.9% | +8.3% | +7.1% |
Valuation Metrics
Evenly matched — FUNC and MNSB and FXNC each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 12.1x trailing earnings, FUNC trades at a 35% valuation discount to CARE's 18.7x P/E. Adjusting for growth (PEG ratio), FUNC offers better value at 1.08x vs FXNC's 9.55x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $248M | $176M | $580M | $253M |
| Enterprise ValueMkt cap + debt − cash | $357M | $221M | $654M | $134M |
| Trailing P/EPrice ÷ TTM EPS | 12.12x | 13.36x | 18.71x | 14.27x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.68x | 10.45x | 4.77x | 11.75x |
| PEG RatioP/E ÷ EPS growth rate | 1.08x | — | — | 9.55x |
| EV / EBITDAEnterprise value multiple | 11.52x | 11.58x | 16.34x | 6.13x |
| Price / SalesMarket cap ÷ Revenue | 2.22x | 1.30x | 2.28x | 2.25x |
| Price / BookPrice ÷ Book value/share | 1.39x | 0.82x | 1.40x | 1.35x |
| Price / FCFMarket cap ÷ FCF | 12.18x | 16.57x | 18.25x | 12.03x |
Profitability & Efficiency
FXNC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
FUNC delivers a 12.5% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $7 for MNSB. FXNC carries lower financial leverage with a 0.23x debt-to-equity ratio, signaling a more conservative balance sheet compared to FUNC's 1.05x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs MNSB's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.5% | +7.3% | +7.6% | +10.0% |
| ROA (TTM)Return on assets | +1.2% | +0.7% | +0.7% | +0.9% |
| ROICReturn on invested capital | +5.9% | +5.0% | +5.7% | +7.7% |
| ROCEReturn on capital employed | +8.5% | +0.9% | +1.5% | +9.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 8 | 7 |
| Debt / EquityFinancial leverage | 1.05x | 0.32x | 0.43x | 0.23x |
| Net DebtTotal debt minus cash | $109M | $45M | $73M | -$118M |
| Cash & Equiv.Liquid assets | $78M | $25M | $105M | $161M |
| Total DebtShort + long-term debt | $188M | $70M | $179M | $43M |
| Interest CoverageEBIT ÷ Interest expense | 1.01x | 0.31x | 0.39x | 0.84x |
Total Returns (Dividends Reinvested)
FUNC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FUNC five years ago would be worth $23,452 today (with dividends reinvested), compared to $12,056 for MNSB. Over the past 12 months, CARE leads with a +69.0% total return vs MNSB's +26.4%. The 3-year compound annual growth rate (CAGR) favors FUNC at 47.1% vs MNSB's 6.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +4.4% | +19.4% | +34.8% | +14.6% |
| 1-Year ReturnPast 12 months | +27.8% | +26.4% | +69.0% | +46.9% |
| 3-Year ReturnCumulative with dividends | +218.6% | +21.5% | +94.7% | +110.8% |
| 5-Year ReturnCumulative with dividends | +134.5% | +20.6% | +87.2% | +68.7% |
| 10-Year ReturnCumulative with dividends | +289.2% | +126.9% | +112.9% | +241.1% |
| CAGR (3Y)Annualised 3-year return | +47.1% | +6.7% | +24.9% | +28.2% |
Risk & Volatility
CARE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than FUNC's 0.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 98.5% from its 52-week high vs FUNC's 91.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 0.66x | 0.56x | 0.70x |
| 52-Week HighHighest price in past year | $41.95 | $25.17 | $26.58 | $29.85 |
| 52-Week LowLowest price in past year | $28.00 | $17.86 | $15.37 | $18.31 |
| % of 52W HighCurrent price vs 52-week peak | +91.0% | +93.4% | +98.5% | +93.7% |
| RSI (14)Momentum oscillator 0–100 | 50.6 | 50.4 | 75.4 | 47.6 |
| Avg Volume (50D)Average daily shares traded | 11K | 58K | 276K | 80K |
Analyst Outlook
FXNC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FUNC as "Buy", MNSB as "Hold", CARE as "Buy", FXNC as "Buy". Consensus price targets imply 3.1% upside for CARE (target: $27) vs -34.5% for FUNC (target: $25). For income investors, FXNC offers the higher dividend yield at 2.19% vs FUNC's 2.15%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $25.00 | — | $27.00 | $21.00 |
| # AnalystsCovering analysts | 1 | 1 | 4 | 1 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | — | — | +2.2% |
| Dividend StreakConsecutive years of raises | 7 | 2 | 0 | 11 |
| Dividend / ShareAnnual DPS | $0.82 | — | — | $0.61 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | 0.0% | +3.4% | +0.1% |
FXNC leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FUNC leads in 1 (Total Returns). 1 tied.
FUNC vs MNSB vs CARE vs FXNC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FUNC or MNSB or CARE or FXNC a better buy right now?
For growth investors, First National Corporation (FXNC) is the stronger pick with 27.
1% revenue growth year-over-year, versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). First United Corporation (FUNC) offers the better valuation at 12. 1x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate First United Corporation (FUNC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FUNC or MNSB or CARE or FXNC?
On trailing P/E, First United Corporation (FUNC) is the cheapest at 12.
1x versus Carter Bankshares, Inc. at 18. 7x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: First United Corporation wins at 0. 77x versus First National Corporation's 7. 87x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FUNC or MNSB or CARE or FXNC?
Over the past 5 years, First United Corporation (FUNC) delivered a total return of +134.
5%, compared to +20. 6% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: FUNC returned +289. 2% versus CARE's +112. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FUNC or MNSB or CARE or FXNC?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 56β versus First United Corporation's 0. 72β — meaning FUNC is approximately 27% more volatile than CARE relative to the S&P 500. On balance sheet safety, First National Corporation (FXNC) carries a lower debt/equity ratio of 23% versus 105% for First United Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — FUNC or MNSB or CARE or FXNC?
By revenue growth (latest reported year), First National Corporation (FXNC) is pulling ahead at 27.
1% versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to 32. 1% for Carter Bankshares, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FUNC or MNSB or CARE or FXNC?
First United Corporation (FUNC) is the more profitable company, earning 18.
4% net margin versus 11. 5% for MainStreet Bancshares, Inc. — meaning it keeps 18. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FUNC leads at 24. 4% versus 14. 0% for MNSB. At the gross margin level — before operating expenses — FXNC leads at 74. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FUNC or MNSB or CARE or FXNC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, First United Corporation (FUNC) is the more undervalued stock at a PEG of 0. 77x versus First National Corporation's 7. 87x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 4. 8x forward P/E versus 11. 7x for First National Corporation — 7. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: 3. 1% to $27. 00.
08Which pays a better dividend — FUNC or MNSB or CARE or FXNC?
In this comparison, FXNC (2.
2% yield), FUNC (2. 2% yield) pay a dividend. MNSB, CARE do not pay a meaningful dividend and should not be held primarily for income.
09Is FUNC or MNSB or CARE or FXNC better for a retirement portfolio?
For long-horizon retirement investors, First United Corporation (FUNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
72), 2. 2% yield, +289. 2% 10Y return). Both have compounded well over 10 years (FUNC: +289. 2%, MNSB: +126. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FUNC and MNSB and CARE and FXNC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FUNC is a small-cap high-growth stock; MNSB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; FXNC is a small-cap high-growth stock. FUNC, FXNC pay a dividend while MNSB, CARE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.